Grace is an economist with expertise in the methods and processes of value assessment, reimbursement and healthcare decision making. Her current research interests include interactions between health technology appraisal and novel payment mechanisms, particularly in relation to innovative technologies such as cell and gene therapies and new drugs to tackle Antimicrobial Resistance.

Prior to joining OHE in 2014 she worked to develop NICE guidelines, and therefore has first hand experience of HTA and healthcare decision making. 

Grace has a BSc in Economics and MSc in Health Economics from the University of York.